Sector Alpha

Track where the smart money flows in Indian equities

DashboardWeekly UpdateUploadPipelinePE CyclesBrainAbout

Data updated weekly. Not financial advice.

Sector Alpha
  1. Home
  2. /Momentum
  3. /Pharmaceuticals Bulk Drugs & Formulation
  4. /Amanta Healthcare Ltd
MomentumDeep Value

Amanta Healthcare Ltd: Why Is It Outperforming Nifty 500?

Active
RS +26.7%New This Week

In Week of Apr 18, 2026, Amanta Healthcare Ltd (Pharmaceuticals Bulk Drugs & Formulation) is outperforming Nifty 500 with +26.7% relative strength.

Key Numbers

PAT Growth YoY
+8%
Stable
Revenue YoY
+10%
Inflection Up
Operating Margin
20.6%
-159 bps YoY
PE Ratio
31.6
Current Price
₹130
3Y PAT CAGR
-43%
Market Cap
504 Cr
Valuation
N/A

12-Week Performance

Weekly presence in the outperformers list. Green = beating Nifty 500 by 10%+ that week.

12 weeks agoThis week

How Fast Is Amanta Healthcare Ltd Growing?

Revenue, profit and margin growth rates

MetricYoY3Y CAGRTrend
Revenue+10%+7%Inflection Up
PAT (Net Profit)+8%-43%Stable
OPM20.6%-159 bpsVolatile

Other Top Pharmaceuticals Bulk Drugs & Formulation Stocks Beating Nifty 500

Alivus Life Sciences Ltd
Weak • 4w streak
+23.9%
Sudeep Pharma Ltd
+12.7%
← Back to Pharmaceuticals Bulk Drugs & FormulationDashboard

Frequently Asked Questions: Amanta Healthcare Ltd

Based on publicly available financial data. This is educational research, not investment advice.

What were Amanta Healthcare Ltd's latest quarterly results?

Amanta Healthcare Ltd's latest quarterly results (Dec 2025) show

  • PAT Growth YoY: +8.2% (stable)
  • Revenue Growth YoY: +9.9%
  • Operating Margin: 20.6% (volatile)

Is Amanta Healthcare Ltd's profit growing or declining?

Amanta Healthcare Ltd's profit is growing with an stable trend.

  • PAT Growth YoY: +8.2% (latest quarter)
  • PAT Growth QoQ: +282.6% (sequential)
  • 3-Year PAT CAGR: -43.4%
  • Trend: Stable — consistent growth pattern

What is Amanta Healthcare Ltd's revenue growth trend?

Amanta Healthcare Ltd's revenue growth trend is turning around (inflection up).

  • Revenue Growth YoY: +9.9%
  • Revenue Growth QoQ: +5.1% (sequential)
  • 3-Year Revenue CAGR: +6.9%

How is Amanta Healthcare Ltd's operating margin trending?

Amanta Healthcare Ltd's operating margin is volatile.

  • Current OPM: 20.6%
  • OPM Change YoY: -1.6% basis points
  • OPM Change QoQ: -0.1% basis points

What is Amanta Healthcare Ltd's 3-year profit and revenue CAGR?

Amanta Healthcare Ltd's long-term compounding rates

  • 3-Year Profit CAGR: -43.4%
  • 3-Year Revenue CAGR: +6.9%

Is Amanta Healthcare Ltd's growth accelerating or decelerating?

Amanta Healthcare Ltd's earnings growth is stable with mixed signals on a sequential basis.

  • YoY Acceleration: +54.7% bps
  • Sequential Acceleration: +100.0% bps
  • Margin Warning: Operating margins are under pressure

What is Amanta Healthcare Ltd's current PE ratio?

Amanta Healthcare Ltd's current PE ratio is 31.6x.

  • Current PE: 31.6x
  • Market Cap: 504 Cr

What is Amanta Healthcare Ltd's price-to-book ratio?

Amanta Healthcare Ltd's price-to-book ratio is 2.4x.

  • Price-to-Book (P/B): 2.4x
  • Book Value per Share: ₹54
  • Current Price: ₹130

Is Amanta Healthcare Ltd a fundamentally strong company?

Amanta Healthcare Ltd's fundamental strength based on key financial ratios

  • Return on Capital (ROCE): 15.0%

Is Amanta Healthcare Ltd debt free?

Amanta Healthcare Ltd has a debt-to-equity ratio of N/A.

  • Total Debt: ₹186 Cr

What is Amanta Healthcare Ltd's return on equity (ROE) and ROCE?

Amanta Healthcare Ltd's return ratios over recent years

  • FY2023: ROCE 13.0%
  • FY2024: ROCE 14.0%
  • FY2025: ROCE 15.0%

Is Amanta Healthcare Ltd's cash flow positive?

Amanta Healthcare Ltd's operating cash flow is positive (FY2025).

  • Cash from Operations (CFO): ₹47 Cr
  • Free Cash Flow (FCF): ₹23 Cr
  • CFO/PAT Ratio: 470% (strong cash conversion)

What is Amanta Healthcare Ltd's dividend yield?

Amanta Healthcare Ltd currently does not pay a significant dividend (yield 0.00%).

  • Dividend Yield: 0.00%
  • Current Price: ₹130

Who holds Amanta Healthcare Ltd shares — promoters, FII, DII?

Amanta Healthcare Ltd's shareholding pattern (Dec 2025)

  • Promoters: 63.6%
  • FII (Foreign): 1.1%
  • DII (Domestic): 11.2%
  • Public: 24.1%

Is promoter holding increasing or decreasing in Amanta Healthcare Ltd?

Amanta Healthcare Ltd's promoter holding has remained stable recently.

  • Current Promoter Holding: 63.6% (Dec 2025)
  • Previous Quarter: 63.6% (Sep 2025)
  • Change: 0.00% (stable)

How long has Amanta Healthcare Ltd been outperforming Nifty 500?

Amanta Healthcare Ltd has been outperforming Nifty 500 for 1 consecutive week, indicating early-stage outperformance.

Is Amanta Healthcare Ltd a new momentum entry or an established outperformer?

Amanta Healthcare Ltd is a new entry this week — it just started outperforming Nifty 500. New entries are worth monitoring for follow-through.

Is Amanta Healthcare Ltd worth studying for long term investment?

Based on quantitative research signals, here is why Amanta Healthcare Ltd may be worth studying

  • Earnings growing at +8.2% YoY
  • Cash flow is positive — CFO ₹47 Cr

What is the investment thesis for Amanta Healthcare Ltd?

Amanta Healthcare Ltd investment thesis summary:

Risk Factors (Bear Case)

  • Margins under pressure

What is the future outlook for Amanta Healthcare Ltd?

Amanta Healthcare Ltd's forward outlook based on current data signals

  • Earnings Trend: stable
  • Revenue Trend: turning around (inflection up)
  • Margin Trend: volatile

The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.